| Management target | Revenue FY27 |
|---|
| Revenue growth | 60% YoY growth in Q1 FY27. |
|---|---|
| Margins | Significant improvement to 18.76% from 11.08% YoY. |
| Demand visibility | Strong, driven by Tier-II/III healthcare needs and insurance penetration. |
| Management confidence | High, citing strong execution and tangible results. |
Growth
Q1 FY27 revenue grew 60% YoY; profit before tax/depreciation surged 170% YoY with margins expanding to 18.76%.
Outlook
New Anand Hospital acquisition expected to contribute ₹9-9.5 Cr revenue and ₹2.5-3 Cr profit for FY27.
Risks
Regulatory policy changes, market competition, and financing availability cited as potential external risks to performance.
Investor Presentation filed with NSE, NSE: AATMAJ. Summary written with AI assistance from the document.
Aatmaj Healthcare Ltd: key numbers
- Share price
- ₹20.40
- Market cap
- ₹46.10 Cr
- Revenue (annual)
- ₹24.32 Cr
- Net profit (annual)
- ₹0.71 Cr
- P/E (TTM)
- 64.6×Sector 57.8×
- Promoter holding
- 64.33%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aatmaj Healthcare Ltd
All →Aatmaj Healthcare H1 FY26 Results: Net Profit ₹0.5 Cr, Up 66.7% YoY
Aatmaj Healthcare Ltd reported revenue from operations of ₹10.8 Cr (+27.1% YoY) and net profit of ₹0.5 Cr (+66.7% YoY) for H1 FY26.
- Key figure
- Net profit ₹0.5 Cr · +66.7% YoY
Aatmaj Healthcare H2 FY26 Results: Net Profit ₹0.2 Cr, Down 33.3% YoY
Aatmaj Healthcare Ltd reported revenue from operations of ₹13.5 Cr (+22.7% YoY) and net profit of ₹0.2 Cr (-33.3% YoY) for H2 FY26.
- Key figure
- Net profit ₹0.2 Cr · -33.3% YoY